InsidersTradesSigma
Follow the 株式会社サイトリ細胞研究所 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社サイトリ細胞研究所 has recorded 4 insider filings. The latest transaction was reported on 23 June 2023 (Holding update). Among the most active insiders: HG Capital Co.,Ltd.. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
株式会社サイトリ細胞研究所 是一家专注于细胞研究的公司，致力于开发创新疗法。它主要在健康和制药领域运营。